NCT01223534 - QuantiFERON®-TB Gold In-Tube for the Diagnosis of Tuberculosis Infection in Contact Tracing Study. | Biotech Hunter

Enrollment

871

Participants

Timeline

Start Date

July 31, 2010

Primary Completion Date

February 29, 2016

Study Completion Date

February 29, 2016

Conditions

Latent Tuberculosis Infection

Interventions

DRUG

Preventive treatment with Isoniazid.

If TST positive: participant will be treated with Isoniazid 300 mg/d, for 6 months.

DRUG

Preventive treatment with Isoniazid

If QFT-IT positive, Isoniazid 300 mg/d, for 6 months.

Trial Locations (1)

Bellvitge University Hospital, IDIBELL, L'Hospitalet de Llobregat, Barcelona